Structure Therapeutics: Funding, Investors & Team (Sep 2026)
Structure Therapeutics develops groundbreaking medications for patients using cutting-edge computational and structure-based technology. Our innovative platform combines advancements in computational chemistry, visualizing molecular interactions, and integrating data to create highly effective oral medications that surpass current limitations in biologic and peptide drugs. We are progressing our pipeline of differentiated, safe treatments targeting chronic diseases with significant unmet needs, such as cardiovascular, metabolic, and pulmonary conditions. With our team's expertise in complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development, we aim to design and deliver top-quality medications with a profound impact on patients and extensive commercial potential.
Structure Therapeutics has raised $1.3B across 2 funding rounds on record, the most recent an undisclosed round of $748M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Structure Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Structure Therapeutics Funding Rounds
Structure Therapeutics raised $547M in an undisclosed round announced in Jun 2024.
1.5 years later, an undisclosed round of $748M was announced in Dec 2025.
Structure Therapeutics Founders and Leadership Team
Contact details for the Structure Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Structure Therapeutics Funding Compared to Other Biotechnology Startups
Structure Therapeutics' latest round of $748M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Structure Therapeutics in Biotechnology and South San Francisco
Companies Similar to Structure Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Structure Therapeutics Funding FAQs
What does Structure Therapeutics do?
Structure Therapeutics develops groundbreaking medications for patients using cutting-edge computational and structure-based technology. Our innovative platform combines advancements in computational chemistry, visualizing molecular interactions, and integrating data to create highly effective oral medications that surpass current limitations in biologic and peptide drugs. We are progressing our pipeline of differentiated, safe treatments targeting chronic diseases with significant unmet needs, such as cardiovascular, metabolic, and pulmonary conditions. With our team's expertise in complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development, we aim to design and deliver top-quality medications with a profound impact on patients and extensive commercial potential.
How much funding has Structure Therapeutics raised?
Structure Therapeutics has raised $1.3B across 2 rounds on record. The most recent is an undisclosed round of $748M announced in Dec 2025.
When did Structure Therapeutics last raise funding?
Structure Therapeutics' most recent funding round on record is an undisclosed round of $748M, announced in Dec 2025.
Who founded Structure Therapeutics?
FundedIQ lists Raymond Stevens (Founder) at Structure Therapeutics.
Where is Structure Therapeutics headquartered?
Structure Therapeutics is based in South San Francisco, California, United States.
How many employees does Structure Therapeutics have?
Structure Therapeutics is in the 101-250 employee band.
How does Structure Therapeutics' funding compare to other Biotechnology startups?
Structure Therapeutics' latest round of $748M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Structure Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Structure Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.